History
  • No items yet
midpage
Enzo Biochem, Inc. v. Amersham PLC
981 F. Supp. 2d 217
S.D.N.Y.
2013
Read the full case

Background

  • In 1995, Enzo and Amersham entered a Distributorship Agreement, defining Products as those listed in Exhibit B.
  • Exhibit B lists nine pages of Products and transfer prices; Contested Products were not listed.
  • Contested Products include CyDye products, conjugated alkaline phosphatase products, and sequencing kits/components acquired or developed by Amersham.
  • Enzo attempted to expand Exhibit B to cover Contested Products, but negotiations stalled and no amendment was adopted.
  • Enzo filed suit in 2002 asserting patent and non-patent claims; the court later granted summary judgment on patent claims and now addresses non-patent claims.
  • The court concludes there are no viable non-patent claims remaining for Enzo and grants Amersham summary judgment on those counts.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Contested Products are within Exhibit B under the Agreement Enzo contends Contested Products are encompassed by the Agreement. Exhibit B only covers listed Products; no amendment was adopted. Amersham wins; Contested Products are not covered by Exhibit B, so no breach.
Whether Enzo's breach-of-contract claim is timely and properly pleaded Enzo argues broad breaches and preservation via catch-all pleadings. Claims not pleaded or properly pleaded; cannot raise new grounds in briefing. Amersham wins; breach claim barred for lack of pleadings and late amendment.
Whether Amersham tortiously interfered with Enzo's relationship with PerkinElmer Amersham induced CyDye purchases from PerkinElmer in breach of agreements. Claim is time-barred and lacks malice or improper means evidence. Amersham wins; claim time-barred and merit insufficient.
Whether Enzo's state-law unfair competition claim related to Amersham's dealings with Applied Biosystems and PerkinElmer survives Unfair competition protected Enzo against misappropriation and improper dealings. Preempted by federal patent law and unsupported by record; untimely. Amersham wins; preemption and lack of evidence sustain summary judgment.
Whether Enzo's Lanham Act claim for unfair competition can succeed Amersham reverse-passed off Enzo's goods as Amersham's. Enzo was not a producer of tangible goods; origin doctrine bars claim. Amersham wins; Lanham Act claim dismissed.

Key Cases Cited

  • Goldhirsh Group, Inc. v. Alpert, 107 F.3d 105 (2d Cir.1997) (elements of tortious interference require malice or improper means)
  • Kronos, Inc. v. AVX Corp., 81 N.Y.2d 90, 595 N.Y.S.2d 931 (1993) (accrual of tortious interference when all elements can be pleaded)
  • Dastar Corp. v. Twentieth Century Fox Film Corp., 539 U.S. 23, 123 S. Ct. 2041 (2003) (origin of goods limits Lanham Act protections to producers of tangible goods)
  • Silverstein v. Penguin Putnam, Inc., 522 F. Supp. 2d 579 (S.D.N.Y.2007) (author of ideas is not origin of goods for Lanham Act purposes)
  • Sears Roebuck & Co. v. Stiffel Co., 376 U.S. 225 (1964) (patent preemption principles in unfair competition claims)
  • Flexitized, Inc. v. Nat’l Flexitized Corp., 335 F.2d 774 (2d Cir.1964) (unfair competition does not override patent protection)
  • Winston v. Mediafare Entm’t Corp., 777 F.2d 78 (2d Cir.1985) (no duty to negotiate absent a binding amendment)
  • Sporn v. MCA Records, Inc., 88 A.D.2d 857, 451 N.Y.S.2d 750 (1982) (unfair competition is not a continuing tort)
  • Avillan v. Donahoe, 483 F. App’x 637 (2d Cir.2012) (amendment of pleadings not allowed in summary judgment briefing)
  • First Am. Commercial Bancorp, Inc. v. Saatchi & Saatchi Rowland, Inc., 55 A.D.3d 1264, 865 N.Y.S.2d 424 (2008) (catch-all allegations do not preserve contract claims)
Read the full case

Case Details

Case Name: Enzo Biochem, Inc. v. Amersham PLC
Court Name: District Court, S.D. New York
Date Published: Oct 22, 2013
Citation: 981 F. Supp. 2d 217
Docket Number: No. 02 CIV. 8448(RJS)
Court Abbreviation: S.D.N.Y.